Predictive value of baseline serum carbohydrate antigen 19-9 level on treatment effect of neoadjuvant chemoradiotherapy in patients with resectable and borderline resectable pancreatic cancer in two randomized trials
info:eu-repo/semantics/OpenAccess ;ISSN: 0007-1323 ;EISSN: 1365-2168
Digital Resources/Online E-Resources